人源化小鼠模型全球市場報告：趨勢、預測與競爭分析（至 2031 年）

全球人源化小鼠模型市場前景光明，在製藥和生物技術、合約研究組織以及學術和研究機構市場都存在機會。預計到 2031 年，全球人源化小鼠模型市場規模將達到 4.966 億美元，2025 年至 2031 年的複合年成長率為 6.5%。該市場的主要驅動力是對更準確和預測性藥物發現模型的需求不斷成長、對人源化 PDX 模型的需求不斷成長，以及製藥和生物技術領域研發活動的不斷成長。

• Lucintel 表示，根據應用情況，腫瘤學預計在預測期內仍將是最大的細分市場。
• 根據最終用途，預計學術和研究機構在預測期內仍將是最大的組成部分。
• 在各個地區中，北美預計將在預測期內經歷最高的成長，這得益於其強大的醫療保健體系和對生物醫學研究的高額資金投入。

人源化小鼠模型市場的策略性成長機會

人源化小鼠模型市場在關鍵應用領域展現多種策略成長機會。這些機會凸顯了該產業的擴張和創新領域。

• 擴展到新興市場：隨著生物技術領域的發展，人源化小鼠模型在新興市場的發展具有巨大的成長潛力。預計這些地區的投資和基礎設施建設的增加將推動市場成長和研究能力的提高。
• 發展特異性疾病模型：針對特定疾病（例如罕見或複雜疾病）創建人源化小鼠模型代表著一個日益成長的機會。這些模型可以促進針對性治療領域的研究並加速藥物開發。
• 與先進研究技術的融合：人源化小鼠模型與人工智慧、高通量篩檢等尖端研究技術的融合，帶來了成長機會。這種整合將提高研究方法的效率和準確性。
• 增強模型客製化：根據特定研究需求和基因圖譜提供客製化的人源化小鼠模型具有成長潛力。客製化增加了模型在不同研究環境中的相關性和適用性。
• 專注於個人化醫療研究：利用人源化小鼠模型進行個人化醫療研究提供了成長機會。根據個人基因圖譜客製化模型有助於制定個人化治療策略並改善研究成果。

此類策略成長機會凸顯了人源化小鼠模型市場擴張和創新的領域。該領域專注於新興市場、特異性疾病模型和先進研究技術，預計將持續成長並產生影響。

人源化小鼠模型市場的促進因素與挑戰

人源化小鼠模型市場受到各種促進因素​​和挑戰的影響，這些因素和挑戰影響其市場的發展和應用。這些因素包括技術進步、經濟狀況和監管問題。

人源化小鼠模型市場受以下因素驅動：

• 技術進步：基因工程和模型開發的創新正在推動市場發展。 CRISPR/Cas9 等技術進步使得能夠產生更準確、更強大的人源化小鼠模型，進而提升研究能力。
• 增加研究經費：對生物醫學研究和藥物發現的投資不斷增加，推動了對人源化小鼠模型的需求。政府機構和私人組織的資金支持這些模型在各個研究領域的發展和使用。
• 複雜疾病盛行率上升：癌症和自體免疫疾病等複雜疾病的發生率不斷上升，推動了對人源化小鼠模型的需求。這些模型對於研究疾病機制和開發標靶治療至關重要。
• 生物技術和製藥行業的擴張：生物技術和製藥公司的成長正在推動對人源化小鼠模型的需求。這些行業使用先進的模型進行臨床前試驗和藥物開發。
• 重視個人化醫療：重視個人化醫療正在推動人性化小鼠模型的使用。開發適合個人基因特徵的模型將支持個人化治療策略的發展並改善研究成果。

人源化小鼠模型市場的挑戰如下：

• 高成本：人源化小鼠模型的開發與維護成本很高。由於成本高，一些研究機構可能限制獲得人源化小鼠模型，難以獲得人源化小鼠模型。
• 監管障礙：使用人源化小鼠模型的監管要求難以滿足。嚴格的法規和核准流程可能會減緩新車型和新技術的引進。
• 道德考量：在研究中使用動物模型的道德問題可能具有挑戰性。解決這些問題同時確保人源化小鼠模型的有效性對於維護研究的完整性至關重要。

目錄

第1章執行摘要

2. 全球人源化小鼠模型市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球人源化小鼠模型市場趨勢（2019-2024）及預測（2025-2031）
• 全球人源化小鼠模型市場（依模型類型）
  • 遺傳
  • 基於細胞
• 全球人源化小鼠模型市場（按應用）
  • 腫瘤學
  • 免疫學和感染疾病
  • 神經科學
  • 毒理學
  • 造血
  • 其他
• 全球人源化小鼠模型市場（依最終用途）
  • 製藥和生物技術
  • 合約研究組織
  • 學術和研究機構
  • 其他

第4章。各地區市場趨勢及預測分析（2019-2031）

• 全球人源化小鼠模型市場（按地區）
• 北美人源化小鼠模型市場
• 歐洲人源化小鼠模型市場
• 亞太人源化小鼠模型市場
• 世界其他地區人源化小鼠模型市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球人源化小鼠模型市場成長機會（依模型類型）
  • 全球人源化小鼠模型市場的成長機會（按應用）
  • 全球人源化小鼠模型市場成長機會（依最終用途）
  • 全球人源化小鼠模型市場按地區分類的成長機會
• 全球人源化小鼠模型市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球人源化小鼠模型市場產能擴張
  • 全球人源化小鼠模型市場的合併、收購與合資企業
  • 認證和許可

第7章主要企業簡介

• Ingenious Targeting Laboratory
• Axenis
• Trans Genic
• Horizon Discovery Group
• HuMurine Technologies
• Champions Oncology
• genOway
• Crown Bioscience
• Taconic Biosciences
• The Jackson Laboratory

The future of the global humanized mouse model market looks promising with opportunities in the pharmaceutical & biotechnology, contract research organization, and academic & research institution markets. The global humanized mouse model market is expected to reach an estimated $496.6 million by 2031 with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the rising demand for more accurate and predictive drug discovery models, growing demand for humanized PDX models, and expanding R&D activities in the pharmaceutical and biotechnology sectors.

• Lucintel forecasts that, within the application category, the oncology segment will remain the largest segment over the forecast period.
• Within the end use category, academic and research institutions will remain the largest segment over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to a robust healthcare system and sizeable financial investments in biomedical research in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Humanized Mouse Model Market

The humanized mouse model market has been gaining significant attention in recent years due to its increasing demand in biomedical research, drug development, and personalized medicine. Humanized mice are genetically modified to carry human genes, cells, or tissues, allowing researchers to study human diseases, test new treatments, and develop personalized therapies. The market is driven by advancements in genetic engineering, immunology, and biotechnology, which have enabled the creation of highly sophisticated and accurate humanized mouse models. As the demand for humanized mice continues to grow, several emerging trends are shaping the market, driving innovation, and transforming the landscape of biomedical research.

Precision Medicine: The increasing focus on precision medicine is driving the demand for humanized mouse models that can mimic specific human diseases and conditions. Researchers are using humanized mice to develop personalized treatment strategies and test targeted therapies.

Immunotherapy Research: Humanized mouse models are being used to study the human immune system and develop immunotherapies, such as checkpoint inhibitors and CAR-T cell therapies.

Gene Editing Technologies: The advent of gene editing tools like CRISPR/Cas9 has revolutionized the creation of humanized mouse models, enabling precise and efficient genetic modifications.

3D Printing and Organoid Technology: The integration of 3D printing and organoid technology is allowing researchers to create complex humanized mouse models that mimic human organs and tissues.

In Vivo Imaging and Analytical Techniques: Advances in in-vivo imaging and analytical techniques, such as bioluminescence and MRI, are enabling researchers to non-invasively monitor disease progression and treatment responses in humanized mice.

The humanized mouse model market is rapidly evolving, driven by emerging trends in precision medicine, immunotherapy research, gene editing technologies, and analytical techniques. As researchers continue to push the boundaries of innovation, humanized mice are becoming increasingly sophisticated, enabling the development of personalized therapies and targeted treatments. The market is expected to grow significantly in the coming years, driven by the increasing demand for accurate and reliable preclinical models. As the field continues to advance, humanized mouse models will likely play a critical role in transforming our understanding of human diseases and developing effective treatments, ultimately improving human health and well-being.

Recent Developments in the Humanized Mouse Model Market

Recent developments in the humanized mouse model market are advancing the field of biomedical research and drug discovery. These developments are improving the effectiveness and applicability of humanized mouse models.

• Introduction of Next-Generation Models: New humanized mouse models with improved immune system functionality are being developed. These models offer enhanced simulation of human diseases and are crucial for research into immunotherapies and chronic conditions.
• Advancements in Genetic Engineering: The application of advanced genetic engineering techniques, such as CRISPR/Cas9, is enabling the creation of more precise humanized mouse models. This development enhances the accuracy of disease modeling and drug testing.
• Expansion of Applications: Humanized mouse models are being expanded to include studies on a wider range of diseases, including cancer, infectious diseases, and genetic disorders. This broadens the scope of research and accelerates the development of targeted treatments.
• Integration of Advanced Technologies: The integration of advanced technologies, such as high-throughput screening and multi-omics, is improving the functionality of humanized mouse models. These technologies enhance the ability to analyze disease mechanisms and drug responses.
• Global Collaborations: Increased international collaborations between research institutions and biotechnology companies are driving innovation in humanized mouse models. These partnerships are leading to the development of new models and technologies that address diverse research needs.

These developments are advancing the humanized mouse model market by improving model precision, expanding research applications, and fostering global collaboration. They contribute to more effective disease research and drug development.

Strategic Growth Opportunities for Humanized Mouse Model Market

The humanized mouse model market presents several strategic growth opportunities across key applications. These opportunities highlight areas for expansion and innovation within the sector.

• Expansion into Emerging Markets: There is significant growth potential in expanding humanized mouse models into emerging markets with developing biotech sectors. Increased investment and infrastructure in these regions can drive market growth and research capabilities.
• Development of Disease-Specific Models: Creating humanized mouse models tailored for specific diseases, including rare and complex conditions, presents a growth opportunity. These models can facilitate targeted research and accelerate drug development for niche therapeutic areas.
• Integration with Advanced Research Technologies: The integration of humanized mouse models with cutting-edge research technologies, such as artificial intelligence and high-throughput screening, offers growth opportunities. This integration enhances the efficiency and accuracy of research processes.
• Enhancement of Model Customization: Offering customized humanized mouse models based on specific research needs and genetic profiles presents growth potential. Customization can improve the relevance and applicability of models in various research contexts.
• Focus on Personalized Medicine Research: Leveraging humanized mouse models for personalized medicine research provides growth opportunities. Tailoring models to individual genetic profiles supports the development of personalized treatment strategies and enhances research outcomes.

These strategic growth opportunities highlight areas for expansion and innovation in the humanized mouse model market. By focusing on emerging markets, disease-specific models, and advanced research technologies, the sector is poised for continued growth and impact.

Humanized Mouse Model Market Driver and Challenges

The humanized mouse model market is influenced by various drivers and challenges that impact its development and adoption. These factors include technological advancements, economic conditions, and regulatory issues.

The factors responsible for driving the humanized mouse model market include:

• Technological Advancements: Innovations in genetic engineering and model development are driving market growth. Advances such as CRISPR/Cas9 enable the creation of more accurate and functional humanized mouse models, enhancing research capabilities.
• Increased Research Funding: Growing investments in biomedical research and drug discovery are fueling demand for humanized mouse models. Funding from government agencies and private organizations supports the development and use of these models in various research areas.
• Rising Prevalence of Complex Diseases: The increasing incidence of complex diseases, such as cancer and autoimmune disorders, drives the need for humanized mouse models. These models are essential for studying disease mechanisms and developing targeted therapies.
• Expansion of Biotech and Pharmaceutical Industries: The growth of biotech and pharmaceutical companies is driving demand for humanized mouse models. These industries rely on advanced models for preclinical testing and drug development.
• Focus on Personalized Medicine: The emphasis on personalized medicine is increasing the use of humanized mouse models. Tailoring models to individual genetic profiles supports the development of personalized treatment strategies and improves research outcomes.

Challenges in the humanized mouse model market are:

• High Costs: The development and maintenance of humanized mouse models can be expensive. High costs may limit access for some research institutions and impact the affordability of these models.
• Regulatory Hurdles: Navigating regulatory requirements for the use of humanized mouse models can be challenging. Stringent regulations and approval processes may delay the introduction of new models and technologies.
• Ethical Considerations: Ethical concerns related to the use of animal models in research can pose challenges. Addressing these concerns while ensuring the effectiveness of humanized mouse models is crucial for maintaining research integrity.

The drivers and challenges in the humanized mouse model market reflect a dynamic landscape influenced by technological advancements, economic conditions, and regulatory factors. Addressing these challenges while leveraging the drivers can shape the market's future growth and development.

List of Humanized Mouse Model Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies humanized mouse model companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the humanized mouse model companies profiled in this report include-

• Ingenious Targeting Laboratory
• Axenis
• Trans Genic
• Horizon Discovery Group
• HuMurine Technologies
• Champions Oncology
• genOway
• Crown Bioscience
• Taconic Biosciences
• The Jackson Laboratory

Humanized Mouse Model by Segment

The study includes a forecast for the global humanized mouse model market by model type, application, end use, and region.

Humanized Mouse Model Market by Model Type [Analysis by Value from 2019 to 2031]:

• Genetic
• Cell-Based

Humanized Mouse Model Market by Application [Analysis by Value from 2019 to 2031]:

• Oncology
• Immunology & Infectious Diseases
• Neuroscience
• Toxicology
• Hematopoiesis
• Others

Humanized Mouse Model Market by End Use [Analysis by Value from 2019 to 2031]:

• Pharmaceutical & Biotechnology
• Contract Research Organizations
• Academic & Research Institutions
• Others

Humanized Mouse Model Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Humanized Mouse Model Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The below content highlights recent developments by major humanized mouse model producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., recent advancements include the development of next-generation humanized mouse models with enhanced immune system functionality. These models are providing more accurate insights into human diseases and improving the efficacy of immunotherapy research.
• China: China is focusing on expanding the availability of humanized mouse models through increased investment in biotechnology. New models are being developed to study a wider range of diseases, particularly in oncology and infectious diseases, boosting research and development capabilities.
• Germany: Germany has introduced innovative humanized mouse models that integrate advanced genomic techniques. These models are being used to study complex human diseases and assess drug responses more effectively, contributing to precision medicine and personalized therapies.
• India: India is seeing growth in the use of humanized mouse models due to collaborations between research institutions and biotech companies. New models are being developed to study tropical diseases and genetic disorders prevalent in the region, enhancing local research efforts.
• Japan: Japan is advancing the humanized mouse model market with the introduction of models that mimic human tissue microenvironments. These models are improving the study of drug metabolism and toxicology, leading to more reliable preclinical testing and drug development.

Features of the Global Humanized Mouse Model Market

Market Size Estimates: Humanized mouse model market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Humanized mouse model market size by model type, application, end use, and region in terms of value ($M).

Regional Analysis: Humanized mouse model market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different model types, applications, end uses, and regions for the humanized mouse model market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the humanized mouse model market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the humanized mouse model market by model type (genetic and cell-based), application (oncology, immunology & infectious diseases, neuroscience, toxicology, hematopoiesis, and others), end use (pharmaceutical & biotechnology, contract research organizations, academic & research institutions, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Humanized Mouse Model Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Humanized Mouse Model Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Humanized Mouse Model Market by Model Type
  • 3.3.1: Genetic
  • 3.3.2: Cell-Based
• 3.4: Global Humanized Mouse Model Market by Application
  • 3.4.1: Oncology
  • 3.4.2: Immunology & Infectious Diseases
  • 3.4.3: Neuroscience
  • 3.4.4: Toxicology
  • 3.4.5: Hematopoiesis
  • 3.4.6: Others
• 3.5: Global Humanized Mouse Model Market by End Use
  • 3.5.1: Pharmaceutical & Biotechnology
  • 3.5.2: Contract Research Organizations
  • 3.5.3: Academic & Research Institutions
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Humanized Mouse Model Market by Region
• 4.2: North American Humanized Mouse Model Market
  • 4.2.1: North American Market by Application: Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, and Others
  • 4.2.2: North American Market by End Use: Pharmaceutical & Biotechnology, Contract Research Organizations, Academic & Research Institutions, and Others
• 4.3: European Humanized Mouse Model Market
  • 4.3.1: European Market by Application: Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, and Others
  • 4.3.2: European Market by End Use: Pharmaceutical & Biotechnology, Contract Research Organizations, Academic & Research Institutions, and Others
• 4.4: APAC Humanized Mouse Model Market
  • 4.4.1: APAC Market by Application: Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, and Others
  • 4.4.2: APAC Market by End Use: Pharmaceutical & Biotechnology, Contract Research Organizations, Academic & Research Institutions, and Others
• 4.5: ROW Humanized Mouse Model Market
  • 4.5.1: ROW Market by Application: Oncology, Immunology & Infectious Diseases, Neuroscience, Toxicology, Hematopoiesis, and Others
  • 4.5.2: ROW Market by End Use: Pharmaceutical & Biotechnology, Contract Research Organizations, Academic & Research Institutions, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Humanized Mouse Model Market by Model Type
  • 6.1.2: Growth Opportunities for the Global Humanized Mouse Model Market by Application
  • 6.1.3: Growth Opportunities for the Global Humanized Mouse Model Market by End Use
  • 6.1.4: Growth Opportunities for the Global Humanized Mouse Model Market by Region
• 6.2: Emerging Trends in the Global Humanized Mouse Model Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Humanized Mouse Model Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Humanized Mouse Model Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ingenious Targeting Laboratory
• 7.2: Axenis
• 7.3: Trans Genic
• 7.4: Horizon Discovery Group
• 7.5: HuMurine Technologies
• 7.6: Champions Oncology
• 7.7: genOway
• 7.8: Crown Bioscience
• 7.9: Taconic Biosciences
• 7.10: The Jackson Laboratory